These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7053255)

  • 1. Phase II study of doxorubicin and mitomycin in non-small cell bronchogenic carcinoma.
    Coates AS; Fox RM; Woods RL; Levi JA; Tattersall MH
    Cancer Treat Rep; 1982 Jan; 66(1):177-8. PubMed ID: 7053255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma.
    Schulman P; Budman DR; Weiselberg L; Vinciguerra V; Degnan TJ
    Cancer Treat Rep; 1983 Oct; 67(10):943-5. PubMed ID: 6684988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4'-Epidoxorubicin plus cisplatin as first-line therapy in the treatment of small cell bronchogenic carcinoma.
    Lelli G; Casadio M; Giordani S; Giuliotti C; Canova N; Martoni A; Pannuti F
    Chemioterapia; 1987 Apr; 6(2):134-6. PubMed ID: 3036379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of 7-N-(p-hydroxyphenyl)-mitomycin C (KW2083) in patients with advanced non-small cell carcinoma of the lung and metastatic pulmonary tumors.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H; Hoshi A
    Jpn J Clin Oncol; 1985 Mar; 15(1):61-5. PubMed ID: 3981815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bronchial arterial cytostatic perfusion of bronchial cancer].
    Schulz V; Weigand H; Ferlinz R
    Prax Klin Pneumol; 1984 Aug; 38(8):356-65. PubMed ID: 6207520
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination chemotherapy with doxorubicin and mitomycin C in non-small cell bronchogenic carcinoma. Severe pulmonary toxicity from q 3 weekly mitomycin C.
    Doyle LA; Ihde DC; Carney DN; Bunn PA; Cohen MH; Matthews MJ; Puffenbarger R; Cordes RS; Minna JD
    Am J Clin Oncol; 1984 Dec; 7(6):719-24. PubMed ID: 6442103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
    Vogl SE; Wollner D; Kaplan BH; Berenzweig M
    Cancer Treat Rep; 1980; 64(4-5):717-9. PubMed ID: 6159081
    [No Abstract]   [Full Text] [Related]  

  • 9. Doxorubicin, cisplatin, and Corynebacterium parvum in non-small cell bronchogenic carcinoma.
    Drapkin R; Bjornsson S; Naeher C; Higby D; Caracandas J; Wallens WT; Kuberka N; Suh K; Siddiqi N; Henderson ES
    Cancer Treat Rep; 1980; 64(12):1367-9. PubMed ID: 7193520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination of cisplatin-mitomycin-vindesine for inoperable, non-small-cell bronchial cancers. French study group in pneumo-cancerology].
    Kleisbauer JP; Thomas P; Perol M; Taytard A; Poirier R; Collus MJ; Guerin JC; Vergnenegre A; Balmes P; Carles P
    Rev Mal Respir; 1993; 10(4):307-12. PubMed ID: 7694331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
    Dundalek E
    Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532
    [No Abstract]   [Full Text] [Related]  

  • 12. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
    Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
    Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW; Palmer JB; Pratt MA; Clark RA
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract]   [Full Text] [Related]  

  • 15. Monochemotherapy of bronchogenic carcinoma withs special reference to cell type.
    Selawry OS
    Cancer Chemother Rep 3; 1973 Mar; 4(2):177-88. PubMed ID: 4277763
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II trial of bisantrene for unresectable non-small cell bronchogenic carcinoma: an Illinois Cancer Council study.
    McGuire WP; Blough RR; Cobleigh MA; Johnson CM; Kukla LJ; Lad TE; Lanzotti VJ; Stiff PJ; Zawila P
    Cancer Treat Rep; 1983 Sep; 67(9):841-2. PubMed ID: 6883363
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacokinetics of adriamycin by bronchial artery infusion for non-small cell bronchogenic carcinoma].
    Wang T; Yang H; Wang H
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):395-8. PubMed ID: 11810771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of mitomycin in small cell lung carcinoma.
    McHale MS; Einhorn LH
    Cancer Treat Rep; 1986 May; 70(5):675. PubMed ID: 3011261
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II evaluation of chlorozotocin in advanced bronchogenic carcinoma.
    Creagan ET; Eagan RT; Fleming TR; Frytak S; Kvols LK; Ingle JN
    Cancer Treat Rep; 1979; 63(11-12):2105-6. PubMed ID: 230898
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.
    Langer CJ; Millenson M; O'Dwyer P; Kosierowski R; Alexander R; Litwin S; McAleer CA; Bonjo CA; Ozols R
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):35-41. PubMed ID: 9007119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.